RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · IEX Real-Time Price · USD
4.010
-0.040 (-0.99%)
At close: May 31, 2024, 4:00 PM
4.030
+0.020 (0.50%)
After-hours: May 31, 2024, 7:30 PM EDT
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $139.96 million as of May 31, 2024. Its market cap has decreased by -80.53% in one year.
Market Cap
139.96M
Enterprise Value
4.71M
1-Year Change
-80.53%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since November 1, 2019, RAPT Therapeutics's market cap has decreased from $270.30M to $139.96M, a decrease of -48.22%. That is a compound annual growth rate of -13.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 140.00M | -0.99% |
May 30, 2024 | 141.40M | 2.54% |
May 29, 2024 | 137.90M | -3.02% |
May 28, 2024 | 142.20M | -2.54% |
May 24, 2024 | 145.90M | -6.77% |
May 23, 2024 | 156.50M | -3.16% |
May 22, 2024 | 161.60M | 0.87% |
May 21, 2024 | 160.20M | 14.76% |
May 20, 2024 | 139.60M | -0.99% |
May 17, 2024 | 141.00M | -2.42% |
May 16, 2024 | 144.50M | -2.50% |
May 15, 2024 | 148.20M | 6.16% |
May 14, 2024 | 139.60M | -9.11% |
May 13, 2024 | 153.60M | 1.65% |
May 10, 2024 | 151.10M | -7.13% |
May 9, 2024 | 162.70M | -41.41% |
May 8, 2024 | 277.70M | -1.24% |
May 7, 2024 | 281.20M | -2.40% |
May 6, 2024 | 288.10M | -0.62% |
May 3, 2024 | 289.90M | 2.55% |
May 2, 2024 | 282.70M | -0.67% |
May 1, 2024 | 284.60M | 6.23% |
Apr 30, 2024 | 267.90M | -2.30% |
Apr 29, 2024 | 274.20M | -2.73% |
Apr 26, 2024 | 281.90M | 3.87% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vaxart | 144.12M |
Quipt Home Medical | 143.04M |
Cardiff Oncology | 142.22M |
TruBridge | 141.22M |
scPharmaceuticals | 140.97M |
Harvard Bioscience | 137.67M |
TELA Bio | 136.34M |
Syros Pharmaceuticals | 136.31M |